Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF

Santen Pharmaceutical Co (SNPHF) Stock Price & Analysis

6 Followers

SNPHF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.21 - $12.24
Previous Close$11.35
Volume405.00
Average Volume (3M)514.00
Market Cap
$4.12B
Enterprise Value$3.72B
Total Cash (Recent Filing)¥62.32B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)22.6
Beta0.33
Aug 06, 2024
Dividend Yield1.98%
Share Statistics
EPS (TTM)0.51
Shares Outstanding363,996,254
10 Day Avg. Volume3,226
30 Day Avg. Volume514
Standard Deviation0.09
R-Squared0.04
Alpha-0.00535
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%2.57%5.40%92.03%
0.00%
Insiders
5.40% Other Institutional Investors
92.03% Public Companies and
Individual Investors

SNPHF FAQ

What was Santen Pharmaceutical Co Ltd’s price range in the past 12 months?
Santen Pharmaceutical Co Ltd lowest stock price was $8.21 and its highest was $12.24 in the past 12 months.
    What is Santen Pharmaceutical Co Ltd’s market cap?
    Currently, no data Available
    When is Santen Pharmaceutical Co Ltd’s upcoming earnings report date?
    Santen Pharmaceutical Co Ltd’s upcoming earnings report date is Aug 06, 2024 which is in 11 days.
      How were Santen Pharmaceutical Co Ltd’s earnings last quarter?
      Santen Pharmaceutical Co Ltd released its earnings results on May 09, 2024. The company reported $0.104 earnings per share for the quarter, missing the consensus estimate of $0.111 by -$0.007.
        Is Santen Pharmaceutical Co Ltd overvalued?
        According to Wall Street analysts Santen Pharmaceutical Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Santen Pharmaceutical Co Ltd pay dividends?
          Santen Pharmaceutical Co Ltd pays a Annually dividend of $0.11 which represents an annual dividend yield of 1.98%. See more information on Santen Pharmaceutical Co Ltd dividends here
            What is Santen Pharmaceutical Co Ltd’s EPS estimate?
            Santen Pharmaceutical Co Ltd’s EPS estimate is $0.14.
              How many shares outstanding does Santen Pharmaceutical Co Ltd have?
              Santen Pharmaceutical Co Ltd has 363,996,250 shares outstanding.
                What happened to Santen Pharmaceutical Co Ltd’s price movement after its last earnings report?
                Santen Pharmaceutical Co Ltd reported an EPS of $0.104 in its last earnings report, missing expectations of $0.111. Following the earnings report the stock price went up 2.518%.
                  Which hedge fund is a major shareholder of Santen Pharmaceutical Co Ltd?
                  Currently, no hedge funds are holding shares in SNPHF
                  ---

                  Santen Pharmaceutical Co Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  33.07%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  8.83%
                  Trailing 12-Months
                  Asset Growth
                  -9.03%
                  Trailing 12-Months

                  Company Description

                  Santen Pharmaceutical Co Ltd

                  Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Other segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Alcon
                  AstraZeneca
                  Bayer
                  GlaxoSmithKline
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis